Cargando…
Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway
Lung adenocarcinoma (LUAD) is one of the leading causes of cancer-related death worldwide. There is an urgent need to uncover the pathogenic mechanism to develop new treatments. Agmatinase (AGMAT) expression and its association with clinicopathological characteristics were analyzed via GEO, Oncomine...
Autores principales: | Zhu, Hui-er, Yin, Jia-yi, Chen, De-xiong, He, Sheng, Chen, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838094/ https://www.ncbi.nlm.nih.gov/pubmed/31699997 http://dx.doi.org/10.1038/s41419-019-2082-3 |
Ejemplares similares
-
Agmatinase facilitates the tumorigenesis of pancreatic adenocarcinoma through the TGFβ/Smad pathway
por: Zhang, Yue, et al.
Publicado: (2022) -
Structure of the E. coli agmatinase, SPEB
por: Chitrakar, Iva, et al.
Publicado: (2021) -
Guanidino acid hydrolysis by the human enzyme annotated as agmatinase
por: Sinn, Malte, et al.
Publicado: (2022) -
ENKUR acts as a tumor suppressor in lung adenocarcinoma cells through PI3K/Akt and MAPK/ERK signaling pathways
por: Ma, Qing, et al.
Publicado: (2019) -
LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway
por: Wei, Chunhua, et al.
Publicado: (2019)